News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|December 21, 2023

Unmet Needs and Treatment Approaches in Newly Diagnosed Multiple Myeloma

Episodes in this series

EP. 1 Unmet Needs and Treatment Approaches in Newly Diagnosed Multiple Myeloma

EP. 1 Unmet Needs and Treatment Approaches in Newly Diagnosed Multiple Myeloma

Video 2 - "ASH 2023: PERSEUS Trial Overview"

EP. 2 ASH 2023: PERSEUS Trial Overview

Video 3 - "Considerations for Combination Therapy and MRD Testing in Newly Diagnosed Multiple Myeloma Patients"

EP. 3 Considerations for Combination Therapy and MRD Testing in Newly Diagnosed Multiple Myeloma Patients

Video 4 - "ASH 2023: Analyzing IsKia Trial"

EP. 4 ASH 2023: Analyzing IsKia Trial

Video 5 - "Examining Data from MonumenTAL-2 Study"

EP. 5 Examining Data from MonumenTAL-2 Study

Video 6 - "Optimizing Bispecific Use in Multiple Myeloma Treatment"

EP. 6 Optimizing Bispecific Use in Multiple Myeloma Treatment

Video 7 - "Navigating Impact of RRMM Treatment on Patient Quality of Life"

EP. 7 Navigating Impact of RRMM Treatment on Patient Quality of Life

Video 8 - "Key RRMM-Related Takeaways from ASH 2023"

EP. 8 Key RRMM-Related Takeaways from ASH 2023

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Early Data Show Feasibility of in Vivo CAR T Therapy in Multiple Myeloma

ByKrina Patel, MD, MSc

January 22nd 2026

An expert featured in this series.

Overarching Themes in MCL at ASH 2025

ByMichael Wang, MD

January 22nd 2026

RPM Shows Promise for Safer, More Feasible Outpatient Bispecific Administration

ByTara Graff, DO

January 22nd 2026

An expert featured in this series.

Translational Research at ASH 2025 Illuminate Resistance, Risk Stratification in MCL

ByMichael Wang, MD

January 22nd 2026

MajesTEC-3 and the Future of Combination Regimens in Multiple Myeloma

ByKrina Patel, MD, MSc

January 22nd 2026

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Trending on AJMC

Novel CLL Therapies Prompt New Treatment Considerations

Congress Unveils Massive Funding Bill to Avert Shutdown

Early Data Show Feasibility of in Vivo CAR T Therapy in Multiple Myeloma

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.